Valion Bio, Inc. Common Stock VBIO
$1.25
-13.79%
at last close
Market Cap$1.29 million
P/E Ratio—
Div Yield—
Volume12.99M
52-Week Range
$1.11$32.50
Key Stats
- Today's Range
- $1.11 – $1.33
- 50-Day Range
- $1.11 – $32.50
- 52-Week Range
- $1.11 – $32.50
- Volume
- 12.99 million shs
- Average Volume
- 2.80 million shs
- Market Cap
- $1.29 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 15.53%
- Days to Cover
- 1.00
About Valion Bio, Inc. Common Stock
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.
Related Stocks
Compare head-to-head: VBIO vs LLY·VBIO vs JNJ·VBIO vs ABBV·VBIO vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.